Brave Asset Management’s Medtronic MDT Stock Holding History

Brave Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-700	Closed	-$60K	–	256
2016 Q3	$60K	Hold	700	–	–	0.04%	208
2016 Q2	$61K	Sell	700 -78	-10%	-$6.31K	0.04%	205
2016 Q1	$58K	Hold	778	–	–	0.04%	208
2015 Q4	$60K	Buy	778 +78	+11%	+$5.87K	0.04%	208
2015 Q3	$47K	Hold	700	–	–	0.04%	213
2015 Q2	$52K	Hold	700	–	–	0.04%	225
2015 Q1	$55K	Hold	700	–	–	0.04%	215
2014 Q4	$51K	Hold	700	–	–	0.04%	225
2014 Q3	$43K	Hold	700	–	–	0.03%	231
2014 Q2	$45K	Hold	700	–	–	0.03%	231
2014 Q1	$43K	Hold	700	–	–	0.03%	230
2013 Q4	$40K	Buy	+700	New	+$39.7K	0.03%	231

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Brave Asset Management's MDT Position: Q4 2016 in Review

Brave Asset Management sold out of Medtronic (MDT) in Q4 2016, closing a stake of 700 shares — an estimated $60K sold.

Brave Asset Management first reported a position in MDT in Q4 2013 and held it in 12 quarters. The position peaked at $61K in Q2 2016. 1,268 funds tracked by Wall St. Rank hold MDT as of Q4 2016.

Brave Asset Management reported no remaining Medtronic position as of Q4 2016 after selling out during the quarter.
Brave Asset Management sold 700 Medtronic shares in Q4 2016, an estimated $60K.
Brave Asset Management first reported a position in Medtronic in Q4 2013 and held it in 12 quarters.
Brave Asset Management's Medtronic position peaked at $61K in Q2 2016.
1,268 funds tracked by Wall St. Rank held Medtronic as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.